Ross Klingsberg, MD
Pulmonary Disease · New Orleans, LANPI 1366532541
Payments from drug & device makers
Across 231 payments — averaging $5010.21 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Vertex$1.1M
- Insmed, Inc.$63K
- Gilead$402
- Chiesi USA, Inc.$288
- Regeneron Healthcare Solutions, Inc.$172
- AbbVie$103
- plus $761 from 17 others
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Vertex | 25 | $1,092,737 |
| Insmed, Inc. | 134 | $62,896 |
| Gilead | 13 | $402 |
| Chiesi USA, Inc. | 9 | $288 |
| Regeneron Healthcare Solutions, Inc. | 7 | $172 |
| AbbVie(2 entities) | 6 | $103 |
| Electromed, Inc. | 6 | $92 |
| Sanofi | 3 | $90 |
| Advanced Respiratory, Inc | 4 | $86 |
| Mylan Specialty L.p. | 4 | $81 |
| Grifols USA, LLC | 3 | $65 |
| Viatris Specialty LLC | 2 | $48 |
| Merck | 2 | $41 |
| Alcresta Therapeutics, Inc. | 2 | $38 |
| AstraZeneca | 2 | $37 |
| Nestle Healthcare Nutrition Inc. | 2 | $32 |
| Merz North America, Inc. | 1 | $30 |
| GSK | 1 | $25 |
| Sunovion Pharmaceuticals Inc. | 1 | $23 |
| Genentech USA, Inc. | 1 | $22 |
| Aimmune Therapeutics, Inc. | 1 | $21 |
| Philips North America LLC | 1 | $15 |
| Paratek Pharmaceuticals, Inc. | 1 | $14 |
How this compares
$1,157,358 in reported general payments places this provider in the 95th percentile of 189 pulmonary disease providers in Louisiana.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other pulmonary disease in New Orleans
- Joseph LaskyNew Orleans$1.9M
- Leonardo SeoaneNew Orleans$1.6M
- Juzar AliNew Orleans$775K
- Ramsy AbdelghaniNew Orleans$474K
- Bennett DeboisblancNew Orleans$457K
- Nereida ParadaNew Orleans$289K
- Nicole LapinelNew Orleans$225K
- Joshua DensonNew Orleans$222K
- Amita KrishnanNew Orleans$205K
- Courtney ShappleyNew Orleans$66K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.